Tyler Kaster

Population of interest Dr. Kaster’s research is focused on the clinical application of interventional psychiatry treatments for severe psychiatric illness. This is accomplished through leading and collaborating on clinical trials of new treatments including repetitive transcranial magnetic stimulation (rTMS), ketamine, magnetic seizure therapy, and psychedelics. It is also accomplished through observational studies leveraging administrative health databases of established treatments such as medications and ECT. He has received funding from the Canadian Institutes for Health Research to conduct both clinical trials of novel interventions as well as epidemiologic work to study the relationship between ECT and real-world outcomes for treatment-resistant psychiatric illness.